Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Nextracker acquisition of Bentek
We advised Nextracker on the acquisition
Orbia $1.1 billion notes offering
We advised Orbia on the investment-grade debt offering
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Bank of America $5 billion floating-rate and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Bank of America $3 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Auna $62.1 million senior secured notes offering
We advised Auna on the offering
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Primo Brands $1.5 billion secondary offering
The shares are listed on the New York Stock Exchange